<SEC-DOCUMENT>0000200406-18-000012.txt : 20180320
<SEC-HEADER>0000200406-18-000012.hdr.sgml : 20180320
<ACCEPTANCE-DATETIME>20180320172716
ACCESSION NUMBER:		0000200406-18-000012
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20180320
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180320
DATE AS OF CHANGE:		20180320

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			JOHNSON & JOHNSON
		CENTRAL INDEX KEY:			0000200406
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				221024240
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			0101

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-03215
		FILM NUMBER:		18702697

	BUSINESS ADDRESS:	
		STREET 1:		ONE JOHNSON & JOHNSON PLZ
		CITY:			NEW BRUNSWICK
		STATE:			NJ
		ZIP:			08933
		BUSINESS PHONE:		732-524-2455

	MAIL ADDRESS:	
		STREET 1:		ONE JOHNSON & JOHNSON PLZ
		CITY:			NEW BRUNSWICK
		STATE:			NJ
		ZIP:			08933
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a20180320form8-kcfo.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s65034342F1783C5D680C402B663B21D7"></a></div><div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">WASHINGTON, DC 20549</font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">FORM 8-K</font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CURRENT REPORT</font></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to Section 13 or 15(d) of the</font></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Securities Exchange Act of 1934</font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date of report (Date of earliest event reported):   March 20, 2018</font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:center;"><img src="a201503form8kcontroll_image1.gif" alt="a201503form8kcontroll_image1.gif" style="height:62px;width:241px;"></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Exact name of registrant as specified in its charter)</font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:84.375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:31%;"></td><td style="width:38%;"></td><td style="width:31%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">New Jersey</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">I-3215</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">22-1024240</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(State or Other Jurisdiction of Incorporation)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(Commission File Number)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(IRS Employer Identification No.)</font></div></td></tr></table></div></div><div style="line-height:144%;padding-top:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">One Johnson &amp; Johnson Plaza, New Brunswick, New Jersey&#160;&#160;08933</font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Address of Principal Executive Offices)  &#160;(Zip Code)</font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Registrant's telephone number, including area code:  732-524-0400</font></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:144%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:144%;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 5.02.&#160;&#160;Departure of Directors of Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements for Certain Officers.</font></div><div style="line-height:120%;padding-top:15px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 20, 2018, the Company issued a press release announcing that Dominic J. Caruso, the Company's Executive Vice President, Chief Financial Officer, has elected to retire in September 2018. The Company also announced that Joseph Wolk, Vice President of Investor Relations for Johnson &amp; Johnson, has been appointed Executive Vice President, Chief Financial Officer, effective July 1, 2018. Mr. Wolk will report to Alex Gorsky, the Company's Chairman and Chief Executive Officer, and become a member of the Company's Executive Committee.</font></div><div style="line-height:120%;padding-top:15px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;">Mr. Wolk, 51, has led the Investor Relations organization since August 2016. Previously, he was Vice President, Group Finance for the Pharmaceuticals Group and a member of the Pharmaceuticals Group Operating Committee. In 2010, Mr. Wolk became Vice President, Finance for the Medical Devices Global Supply Chain and a member of its Management Board, before being named to the Pharmaceuticals position in 2014. Prior to that, Mr. Wolk served as</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">Chief Financial Officer of the North America Pharmaceuticals Group, responsible for Centocor Ortho Biotech Inc., as well as U.S. Pricing Strategy and Compliance.  Mr.&#160;Wolk joined Johnson &amp; Johnson in 1998 as a Finance Manager in the Ortho-McNeil Pharmaceutical organization.</font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 9.01  Financial Statements and Exhibits.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:174%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(d) &#160;&#160;&#160;&#160;Exhibits.&#160;&#160;&#160;&#160;</font></div><div style="line-height:174%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Exhibit No.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Description</font></div><div style="line-height:174%;text-align:justify;text-indent:96px;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="a20180320pressrelease.htm"><font style="font-family:inherit;font-size:10pt;">99.1</font></a><font style="font-family:inherit;font-size:10pt;">Johnson &amp; Johnson press release dated March 20, 2018.</font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURES</font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:83.7890625%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:47%;"></td><td style="width:7%;"></td><td style="width:21%;"></td><td style="width:25%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Johnson &amp; Johnson</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:2px;padding-left:4px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;(Registrant)</font></div><div style="padding-left:4px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="padding-left:4px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="padding-bottom:2px;padding-left:4px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March 20, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Thomas J. Spellman III</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:2px;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thomas J. Spellman III</font></div><div style="padding-bottom:2px;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Secretary</font></div></td></tr></table></div></div><div style="line-height:144%;padding-top:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a20180320pressrelease.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s72A2023BBCE6C3526E07403C3859DD93"></a></div><div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:144%;text-align:right;padding-left:432px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibit 99.1</font></div><div style="line-height:144%;text-align:left;padding-left:432px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:9px;text-align:center;"><img src="a201503form8kcontroll_image1.gif" alt="a201503form8kcontroll_image1.gif" style="height:62px;width:241px;"></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:95.51282051282051%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:21%;"></td><td style="width:27%;"></td><td style="width:27%;"></td><td style="width:25%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Investor Contact:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Lesley Fishman</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Media Contact:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ernie Knewitz</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(732) 524-3922</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(732) 524-6623</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(917) 697-2318 (M)</font></div></td></tr></table></div></div><div style="line-height:216%;padding-top:4px;text-align:left;padding-left:432px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Dominic J. Caruso to Retire as Chief Financial Officer of Johnson &amp; Johnson</font></div><div style="line-height:120%;padding-bottom:10px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Joseph Wolk Promoted to Executive Vice President, Chief Financial Officer</font></div><div style="line-height:120%;padding-bottom:10px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">NEW BRUNSWICK, N.J., March 20, 2018 -- Johnson &amp; Johnson today announced that Dominic J. Caruso, Executive Vice President, Chief Financial Officer, has elected to retire in September 2018 after a distinguished 19-year career with the Company.  Caruso was named CFO in 2007, and served as CFO longer than anyone in the company&#8217;s 132- year history. </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">"During his nearly 12 years as CFO, Dominic provided Credo-based leadership and financial stewardship through the economic downturn and was instrumental in helping the Company deliver significant gains over the past five years," said Alex Gorsky, Chairman and Chief Executive Officer of Johnson &amp; Johnson. "Dominic made a big impact inside our company, and he is well-respected throughout our industry.  We wish Dominic, his wife, Debbie, and their family the very best in the years ahead.&#8221;  </font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Under Mr. Caruso&#8217;s leadership, the Company completed three of its largest acquisitions: Actelion, Synthes and Pfizer Consumer Health.  He was also instrumental in driving growth and capital allocation strategies that led Johnson &amp; Johnson to exceed our competitor composite, as well as most major indices, for total shareholder return in 2017 and over the last three-, five-, ten- and twenty-year periods.  Throughout his career, he has placed an emphasis on teaching, coaching and developing future leaders.  Mr. Caruso and his finance organization have established a best-in-class Talent Development program and have been stewards of sustainable financial principles.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Outside of Johnson &amp; Johnson, he serves on the CNBC CFO Council and is Co-Chair of the U.S. Chamber of Commerce Global Initiative on Health and the Economy.  He was recently recognized as the #1 CFO in the Pharmaceutical sector by </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">Institutional Investor</font><font style="font-family:inherit;font-size:12pt;">. And he serves on the Board of Trustees for The Children&#8217;s Hospital of Philadelphia and the Cystic Fibrosis Foundation.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Joseph Wolk, Vice President of Johnson &amp; Johnson Investor Relations, has been appointed Executive Vice President, Chief Financial Officer, effective July 1, 2018.  He will report to Mr. Gorsky and become a member of the Executive Committee.  Mr. Caruso and Mr. Wolk will work closely during the six-month transition.</font></div><div><br></div><div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1</font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Mr. Wolk has been with Johnson &amp; Johnson for 19 years and has served on the Finance Leadership team, reporting directly to Mr. Caruso since 2014.  Previously, he was Vice President, Finance and CFO of the Janssen Pharmaceutical Companies of Johnson &amp; Johnson and was a member of the Janssen Group Operating Committee. Prior to this role, he held many senior roles in Pharmaceuticals, Medical Device and Supply Chain.  </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">"Joe is a strong, collaborative, Credo-based leader who has a long track record of success, most recently as head of Investor Relations.  In this role, he quickly developed relationships with the investment community and has proven business acumen as well as a deep understanding of the many facets of Johnson &amp; Johnson," Mr. Gorsky said. "His varied experience has brought innumerable benefits to the corporation and we look forward to the valuable contributions he will make in his new role."</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Mr. Wolk holds a J.D. from Temple University School of Law and a B.S. in Finance from St. Joseph&#8217;s University, where he currently serves on the Haub School Board of Visitors.  Mr. Wolk is also a certified public accountant.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">About Johnson &amp; Johnson </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">At Johnson &amp; Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That&#8217;s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world&#8217;s largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Note to Investors Concerning Forward-Looking Statements </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">This press release contains &#8220;forward-looking statements&#8221; as defined in the Private Securities Litigation Reform Act of 1995. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson &amp; Johnson. A list and descriptions of risks, uncertainties and other factors can be found in Johnson &amp; Johnson's Annual Report on Form 10-K for the fiscal year ended December 31, 2017, including in the sections captioned &#8220;Cautionary Note Regarding Forward-Looking Statements&#8221; and &#8220;Item 1A. Risk Factors,&#8221; and in the Company&#8217;s subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Copies of these filings are available online at </font><font style="font-family:inherit;font-size:11pt;color:#0000ff;text-decoration:underline;">www.sec.gov</font><font style="font-family:inherit;font-size:11pt;">, </font><font style="font-family:inherit;font-size:11pt;color:#0000ff;text-decoration:underline;">www.jnj.com</font><font style="font-family:inherit;font-size:11pt;">&#32;or on request from Johnson &amp; Johnson. Any forward-looking statement made in this release speaks only as of the date of this release. Johnson &amp; Johnson does not undertake to update any forward-looking statement as a result of new information or future events or developments.</font></div><div style="line-height:216%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2</font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>a201503form8kcontroll_image1.gif
<TEXT>
begin 644 a201503form8kcontroll_image1.gif
M1TE&.#EAM0 O /<  )H<*8\S/HT\.YDC*9@J-9@X)I8U.ZD:'K<-#K@,&;@5
M&ZL:)ZD<-+H:)[@9,JDB'ZDE**8H-J,T/*<Z-:\R-:XT/*X\,:L\.;0D([0B
M+;,K*KDC)+PC+;PN++<G-K<S.I@Y2*4L0:@X1[HM1;@W1KPX5;-$-H]#38]/
M4)5"0))#2)E 1IY!5)153)=26J9%2*E+4Z=26K=#2+=&5;%23K=46*148;M+
M8;E99ZIE9ZQP<+=D;+YB:[]K:+IR:+1R<\H*&LH5&M$.%M0/&MH(%=T.'=$6
M#]45&\H*(L,2),83*\0;),(;+,L3(\H3+,H:(\H;*\D;,]@))M4)-M87)M,8
M-L,B*L(I+,PC(\HC*\4G-\DR)\DS.],C*M<E-],R-^42&>85)N85-_,<,>,C
M+>8I.NHQ+O$A+_\[/,4;0\8I1<<V1L([5-@G1-DM4-HY1]8Q4-,_5=P^5^,J
M1.@W2. \5_\S3/<Y5\%$2\=+4\%,6\M!4,Q&6LI,5,Q)6LE56]E$2-A+5]U<
M7<I)8<979-A(8M5:9]%<=]M4=-M><-!E7<IG:,MG=L-T<\)U?,%\?,MQ<,]R
M?,]Z=\A\?M9E:-9H==9U>.9 0.1%6>I36OQ#2?5,7_A/5N=9:>-><O)+:?U7
M:?Y7<^1I:.=H=^9S<.1S>^%_?/)B;/IH=O!Q:_]S=?YT?+1]@,MX@\-]E=5I
M@-MWA.%OB.=VA?UD@/UM@O]OCOUWAOU\D\& ?J^2CLB'A\R4E\N;F=:"B-N,
ME-J7F-JCFM6DIM2PLN>&B>N'E.23AN>6F/B(B_V(EOV2BON6F.6;I?J)H?V9
MI?^=LNJADOJKGNFEI^:JMNBTJOBFJ?ZHM/RTK/ZVN?^LQ/VXQ?^\TNK!N_[#
MNO;&Q/_#P__#RO_*QO[*R__)U?_0Q__4S?[8V?_*X?_;Y?_>\/_CV__RWNCN
M[.SWZ^O\]_/K[/_CY/_DZ_[KY/[KZ__D\__E^O[L\__L^OWTZ_3V]/3U^O3]
M]/3^_?[S\_[T^_W[]/[^_BP     M0 O $<(_P#_"1Q(\-^^@P43*D1H\. ^
M@0P52IQ(L:+%BA$;0GQXL:/'CP7Q"?3WCV1)C"7]J03)LN7$?OU.CA08$Z)"
ME?[N<:SILB?(?N$\.# '[UH60/(6"N27$QZ)!K:0Z:GWCY] =@=KFBRI[U_,
MF/O:\:QJD*!*JPV[BOR7;VF[@C'C67(PRQZ].U&HW;NWE>Q ?^F>9:$B3L2U
MF.W:<91)L"M!M&];CI6XN.2]N;3DE0,2ALNU>,F.'"DG4%ZZ M/NO<O0!%6$
M;.^>@A)G@%LZ3E3HH.KU;I4"#N*0$4IG38H86^?>R:B"R9Z]?_>0K;G'#YL#
M)[8BB /W((LM>?SD\?^(\ND;+"U>UI0KETU*FW/U.CW!0$D>O"Y!CJ7+J:X8
MC7?Q'$/%&*@P4@\U01#6B@[Q7'- %JA\$ XX&"R!BC@@1)..)D<T -\U3CCA
M#4GVG"/"+_*\T\<1:&!R"SR5!+%%//S4N%!E_O 32R7WQ),- =)095)E/A5I
MI%<8AG./>#/,4Q-:1T8I957U,#7EE5+6R%=?6'8)4D9>AAFE0QN):29E'*E4
M3R\&7"-.!.$L51"13FEQ#@B^5'EFD:J)4,DYK3@"3U(V#:15=!XHTPP(>NY9
M9'P-+&*?+**5PX\]VO#AP2+7>("*!\W,,T\U40!Q3#SQ=-* ![ (!,\Q"EC_
M@4.5U3@0!03R^"./. #,4,Y>U9  A0+0^&!"*A^(D\T,'BQ  3?\S*-&%5HT
M0U5*CNV58S8>/'"-/.=0084I\=@S#S(1&"".''5T(L,Y\)CSB115O'-/-FH$
M<<4[_=23#1RW7K.D'PTTH$Q2\BP2P37JW'-.(<,J @X$J%B@3#FRC." %8+<
M4P\S:52Q!CR%_I503CG6,\@GMC10B9/]R!..#!FL44HY7_7S PPX>[7+"\I<
MRT\U*4QC53_?R*"'."6]$P,(O3#%3D[#D!#!#,90)U Y*.0 #TSW_'+U.57A
M!-X]P 2#5HW6<%%-!A"(\U4YQT10 2'4H.4O"]58_YG.'S*$8Q4_Y\3 "#HP
MR?/("\U\/<\R(.  SUGW@$-(!'Z2HPX[7BTC0C9,^7,.#"+XPI1C%?FS# &_
MIJ/N9(Z>Z4]LF=T#BR5\C>0/ZK'W[OOO)P,O_/#$HU2\F&$1>1&9QW?$D?()
M*<]\\Q8YI!(\XO!P@C!04J1K-3M$8R/U-U;%3SW+/#W/13F50PPC[WA%_D#0
M\R.. VNHHTX@6A!*_V(P.9\C/%4. D0C=V!J7HX\X8%KI,,9#CC@[BA3$G%$
MH0KD,,8+_#<_W0VD'J6 P"+@48]A4"$+\1-(/7*RE[TL!1X4:  =""$/>6AK
M(-'*U4!0M15^W#!'50'/.__  Z5ZS*.(5>+'DQCCCX><8P 9 !T\&K"$K%GE
M+#;4&E/B@0SCD$ OJ@'/0-Y1HZ.QT'_]@ <_PE(5Y]3#B/78DA++2!(EOE$C
M%N%',Z) @G/< T%': 8U"("*(E!!'OW(!B,T ($:4$,<6F@ ,LHA V5X00J@
MF$<]:G ,301A#>= AB=0 04(G$,>G8J"%.[@@5*<8Q1,6$4][&$,&;Q!"]Z0
M!P0Y\,@1D$J2H?-'/08%CV8, !;O>,<%,*",\ZTA"&\0QR *,8<$4.,=YX"%
M#"Y @&-<0T!->$<T<-",(P0A'4/S90.TH QQ5( :5J#"*H98B#(480B@(($X
MM"'_!2C\2AR'B(,'+'&.<P#B"&8H1R5D08LP=(&,'6%A-B(PBF9(@0JC$"(7
M@. %6V@#&9MZXSD\@ 0FG,-<'VB"%V"0*WD(8@E1^(X\5I$ )>P!1=58 S.T
M4 D;4F,)5*C6-40! 67$XQ[7:  0M)".>Y#C &&X@QJ88<-J,"($ /# !_+0
MC&[<(QPU($$V[$ %")3#.;:(0A+>4(UF=,(#XG@C,:8@!EF0D!I'"(,#JI&3
M;$1!"6H 4#@R (0YC$ <Y0":%@9 CAY]@0P-0$4VFF$%I/1C'GRXZ##D 4(@
MC"$4(G@'E[B$PWJT0A?IN 8$7D$/JQPD)TH42&2\TH^<_]#6'FUQ53]<6S8Q
MCD1K\CM)/^@Q%IB0I2M,42)8%K,5?\#$'"DHQSLN)SB$Q(PI8'D+"R<H/Y.@
MA2?M8"%!.+@3X\:DCJ49B#M@ CN*V$\$XMA+,TKPG Y&21Z5, 1?W@&#O)V7
MM/9MB3_N-P4WA!;  6:)KCK1AB@P(&LD@5Z"C3?AWJVDPE*2,(:/=.&$Z(-W
M&_Y2B(FGX0 G<,1G@EZ)$WQB%!^)>2UV\?)6/)$8RY@@"61>>SO($.K4J!X<
MK(B/DX)@ZNTCMSXLXS^N95SEP?9L:YDP0QY2(V/,H!J54-M%]$@"600@&[NM
M\-3N48X81"(;(G#21IP\NQGPP?\0+K!*E"N<(W1=$QD,(%N'2Z;$I(+B'#7(
MDVMI##S"B6 &!7V!+K2VW)/%8PU1^$8STER6^2DO9H2(PBWBD0X.<.$>(UG,
M3J@4@PRLHAH2*,=6;%QH;SA #35$15[XPCG8/02I54!".1HQB6L%6"4<J8<R
M(/"N>33C"5_0R=H& FKHJ 8 6K#%&AHW1U _!"87UI9(C*N/:R^E)CSA2\RN
M\EOO&NHQ\;@ !YIAKC8X02\=+NY>BI&$,@C'MUD9R='ZX0Z<R&DCZZ )3283
M;IH0"L0F^R!1(<%965#A"4F!R>-:8(U%U*!O(LT %1KPC7240Q("B-,^PE,*
M"02C-,C_$ $N",4/5FRC1SER7PU:,(X>]$!P_<CF#!S!67LLZP4].YD_WO*-
M#T#@&H1;PA.,H=QZE",'/_!&#'1A*7[  QEBD((L4D0-&5#"1D,3 0S(V(\R
M _UHXK#!"O71+RROH!FPJ $PFHI*'+S &BJ91RM"T(Q&5X0?J&A #6JHC" <
MX5OBF$$3J'"-<HR@%IOP #)NH(8D4,$6Q-&"N%!1CWZ(XP!DH$*3X#$#+U"!
M [^2AR&TL-==$\(65"A#.:@Q 64 8@TBN 4RM,!,>!!C#E)P C*NZ&]^4,,'
MX= , #!PC7J< PI4$ 4VS], 0YPC%&X *24J00(M2&$.\2A'_Z;#@(!?U:,2
M59 "!XQJC#<@H374R48#G@ (XDC@%F2U!CGP@ I5:  /?N ,;R $E[ >)9!^
M7N DN14]9E$.0I$-\F -05 $F+ PQP &9! __5(.)@ -\7 .&; $JW ,E% .
M'T %J' .&E0.FD %@/ -8J4*#: !ZT$(R-!%4H <[_ "4&$/,%%,'K DU> !
M#= ,J$ +WX !&W ,6Q(.E2 ".= +V; &?W .Z4 *#7 *LQ0(*L4%B2 .98 %
M1@5DZ3 ,,E . 7($9% .*B .S1 $02!=+U -UX !DH0*J^ -&Q $J  /U"!6
M9Q &56 .QE8%2< 7=G$.;& ,*8('1O^ !M4@ N5 "4> !3128V9!9B.@'NE
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" #L!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
